Intangible assets — net
AbbVie Intangible assets — net decreased by 3.7% to $45.60B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.3%, from $53.20B to $45.60B. Over 5 years (FY 2020 to FY 2025), Intangible assets — net shows a downward trend with a -10.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher values indicate significant investment in proprietary technology or market access, though they require monitoring for potential impairment.
Detailed definition
This represents the net value of identifiable intangible assets with a limited useful life, such as patents, licenses, o...
Peer comparison
Common in technology, pharmaceutical, and defense firms that acquire or develop proprietary intellectual property.
non_current_assets_finite_lived_intangible_assets_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $77.79B | $76.01B | $75.28B | $73.32B | $71.15B | $68.06B | $66.53B | $64.56B | $62.57B | $58.32B | $55.31B | $60.65B | $58.66B | $56.95B | $54.87B | $53.20B | $51.75B | $49.03B | $47.36B | $45.60B |
| QoQ Change | — | -2.3% | -1.0% | -2.6% | -3.0% | -4.4% | -2.2% | -3.0% | -3.1% | -6.8% | -5.2% | +9.7% | -3.3% | -2.9% | -3.7% | -3.0% | -2.7% | -5.2% | -3.4% | -3.7% |
| YoY Change | — | — | — | — | -8.5% | -10.5% | -11.6% | -11.9% | -12.1% | -14.3% | -16.9% | -6.1% | -6.2% | -2.3% | -0.8% | -12.3% | -11.8% | -13.9% | -13.7% | -14.3% |
Product Breakdown
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 |
|---|---|---|---|---|
| Coolsculpting | — | — | — | $1.30B |
| Liletta | — | — | — | $561.00M |
| Imbruvica | $4.80B | $4.30B | $1.90B | — |
| Total | $64.56B | $62.57B | $58.32B | $55.31B |
Imbruvica was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Intangible assets — net at Other Companies
Frequently Asked Questions
- What is AbbVie's intangible assets — net?
- AbbVie (ABBV) reported intangible assets — net of $45.60B in Q1 2026.
- How has AbbVie's intangible assets — net changed year-over-year?
- AbbVie's intangible assets — net decreased by 14.3% year-over-year, from $53.20B to $45.60B.
- What is the long-term trend for AbbVie's intangible assets — net?
- Over 5 years (2020 to 2025), AbbVie's intangible assets — net has grown at a -10.2% compound annual growth rate (CAGR), from $81.00B to $47.36B.
- What does intangible assets — net mean?
- The value of non-physical assets with a limited lifespan, like patents or licenses.